RU2018132042A3 - - Google Patents

Download PDF

Info

Publication number
RU2018132042A3
RU2018132042A3 RU2018132042A RU2018132042A RU2018132042A3 RU 2018132042 A3 RU2018132042 A3 RU 2018132042A3 RU 2018132042 A RU2018132042 A RU 2018132042A RU 2018132042 A RU2018132042 A RU 2018132042A RU 2018132042 A3 RU2018132042 A3 RU 2018132042A3
Authority
RU
Russia
Application number
RU2018132042A
Other languages
Russian (ru)
Other versions
RU2749731C2 (ru
RU2018132042A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2018132042A publication Critical patent/RU2018132042A/ru
Publication of RU2018132042A3 publication Critical patent/RU2018132042A3/ru
Application granted granted Critical
Publication of RU2749731C2 publication Critical patent/RU2749731C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RU2018132042A 2016-02-10 2017-02-10 Применение ингибиторов активности или функции pi3k для лечения первичного синдрома шегрена RU2749731C2 (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP16155123 2016-02-10
EP16155123.9 2016-02-10
EP16186188.5 2016-08-29
EP16186188 2016-08-29
PCT/IB2017/050743 WO2017118965A1 (en) 2016-02-10 2017-02-10 Use of inhibitors of the activity or function of pi3k for the treatment of primary sjögren's syndrome

Publications (3)

Publication Number Publication Date
RU2018132042A RU2018132042A (ru) 2020-03-10
RU2018132042A3 true RU2018132042A3 (US20030204162A1-20031030-M00001.png) 2020-05-15
RU2749731C2 RU2749731C2 (ru) 2021-06-16

Family

ID=58016749

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2018132042A RU2749731C2 (ru) 2016-02-10 2017-02-10 Применение ингибиторов активности или функции pi3k для лечения первичного синдрома шегрена

Country Status (25)

Country Link
US (1) US20190038628A1 (US20030204162A1-20031030-M00001.png)
EP (2) EP3413894B1 (US20030204162A1-20031030-M00001.png)
JP (1) JP7132123B2 (US20030204162A1-20031030-M00001.png)
KR (1) KR20180108651A (US20030204162A1-20031030-M00001.png)
CN (1) CN108601786B (US20030204162A1-20031030-M00001.png)
AU (1) AU2017204936B2 (US20030204162A1-20031030-M00001.png)
BR (1) BR112018015272A2 (US20030204162A1-20031030-M00001.png)
CA (1) CA3011205A1 (US20030204162A1-20031030-M00001.png)
CL (1) CL2018001871A1 (US20030204162A1-20031030-M00001.png)
CY (1) CY1122989T1 (US20030204162A1-20031030-M00001.png)
DK (1) DK3413894T3 (US20030204162A1-20031030-M00001.png)
ES (1) ES2797091T3 (US20030204162A1-20031030-M00001.png)
HK (1) HK1257288A1 (US20030204162A1-20031030-M00001.png)
HR (1) HRP20200916T1 (US20030204162A1-20031030-M00001.png)
HU (1) HUE050632T2 (US20030204162A1-20031030-M00001.png)
IL (1) IL260274A (US20030204162A1-20031030-M00001.png)
LT (1) LT3413894T (US20030204162A1-20031030-M00001.png)
MX (1) MX2018009758A (US20030204162A1-20031030-M00001.png)
PH (1) PH12018501490A1 (US20030204162A1-20031030-M00001.png)
PL (1) PL3413894T3 (US20030204162A1-20031030-M00001.png)
PT (1) PT3413894T (US20030204162A1-20031030-M00001.png)
RS (1) RS60477B1 (US20030204162A1-20031030-M00001.png)
RU (1) RU2749731C2 (US20030204162A1-20031030-M00001.png)
SI (1) SI3413894T1 (US20030204162A1-20031030-M00001.png)
WO (1) WO2017118965A1 (US20030204162A1-20031030-M00001.png)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY158980A (en) 2008-07-17 2016-11-30 Novartis Ag Compositions and methods of use for therapeutic antibodies
UA112517C2 (uk) 2010-07-06 2016-09-26 Новартіс Аг Тетрагідропіридопіримідинові похідні
AR083847A1 (es) 2010-11-15 2013-03-27 Novartis Ag Variantes de fc (fragmento constante) silenciosas de los anticuerpos anti-cd40
MX2013015001A (es) * 2011-06-27 2014-03-31 Novartis Ag Formas solidas y sales de derivados de tetrahidro-pirido-pirimidin a.
WO2015162584A1 (en) * 2014-04-24 2015-10-29 Novartis Ag Crystalline forms of the sulfate salt of n-[5-(3-imidazol-1-yl-4-methanesulfonyl-phenyl)-4-methyl-thiazol-2-yl]-acetamide

Also Published As

Publication number Publication date
EP3413894A1 (en) 2018-12-19
EP3413894B1 (en) 2020-03-11
HUE050632T2 (hu) 2020-12-28
RU2749731C2 (ru) 2021-06-16
CN108601786A (zh) 2018-09-28
MX2018009758A (es) 2018-09-11
JP2019508413A (ja) 2019-03-28
SI3413894T1 (sl) 2020-09-30
WO2017118965A1 (en) 2017-07-13
RS60477B1 (sr) 2020-08-31
CN108601786B (zh) 2021-11-02
HK1257288A1 (zh) 2019-10-18
PL3413894T3 (pl) 2020-10-05
HRP20200916T1 (hr) 2020-09-18
KR20180108651A (ko) 2018-10-04
CL2018001871A1 (es) 2018-11-23
LT3413894T (lt) 2020-07-10
CY1122989T1 (el) 2021-10-29
US20190038628A1 (en) 2019-02-07
EP3695840A1 (en) 2020-08-19
AU2017204936A1 (en) 2018-07-19
DK3413894T3 (da) 2020-06-15
IL260274A (en) 2018-07-31
RU2018132042A (ru) 2020-03-10
PH12018501490A1 (en) 2019-03-25
PT3413894T (pt) 2020-06-16
BR112018015272A2 (pt) 2018-12-18
JP7132123B2 (ja) 2022-09-06
ES2797091T3 (es) 2020-12-01
AU2017204936B2 (en) 2019-06-27
CA3011205A1 (en) 2017-07-13

Similar Documents

Publication Publication Date Title
JP1570578S (US20030204162A1-20031030-M00001.png)
RU2019107694A3 (US20030204162A1-20031030-M00001.png)
JP1590495S (US20030204162A1-20031030-M00001.png)
JP1574981S (US20030204162A1-20031030-M00001.png)
JP1569238S (US20030204162A1-20031030-M00001.png)
RU2018132042A3 (US20030204162A1-20031030-M00001.png)
CN303550335S (US20030204162A1-20031030-M00001.png)
CN303596905S (US20030204162A1-20031030-M00001.png)
CN303608594S (US20030204162A1-20031030-M00001.png)
CN303553673S (US20030204162A1-20031030-M00001.png)
CN303606110S (US20030204162A1-20031030-M00001.png)
CN303605860S (US20030204162A1-20031030-M00001.png)
CN303602368S (US20030204162A1-20031030-M00001.png)
CN303561595S (US20030204162A1-20031030-M00001.png)
CN303600712S (US20030204162A1-20031030-M00001.png)
CN303611825S (US20030204162A1-20031030-M00001.png)
CN303611976S (US20030204162A1-20031030-M00001.png)
CN303578466S (US20030204162A1-20031030-M00001.png)
CN303567785S (US20030204162A1-20031030-M00001.png)
CN303612446S (US20030204162A1-20031030-M00001.png)
CN303553160S (US20030204162A1-20031030-M00001.png)
CN303551294S (US20030204162A1-20031030-M00001.png)
CN303597723S (US20030204162A1-20031030-M00001.png)
CN303553154S (US20030204162A1-20031030-M00001.png)
CN303610871S (US20030204162A1-20031030-M00001.png)